Table 2 FGFR inhibitors under clinical investigation for the treatment of GC
Name or ID | Targets | Phase | NCT identifier |
|---|---|---|---|
Pemigatinib | FGFR1-3 | Phase II Phase I/II | NCT05202236 NCT02393248 |
Futibatinib (TAS-120) | FGFR1-4 | Phase II/I Phase II | NCT02052778 NCT04189445 |
AZD4547 | FGFR1-3 | Phase II | NCT02465060 |
Erdafitinib | FGFR1-4 | Phase II | NCT02699606 |
RLY-4008 | FGFR2 | Phase I | NCT04526106 |